A positive correlation between the frequency of MDSCs and Th17 responses, serum Arg-1 level, and disease severity was observed, which provided new insights into the molecular mechanism targeting MDSCs for the treatment of SLE [58]. The gene discussed is ARG1; the disease is systemic lupus erythematosus.